Literature DB >> 1939657

Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia.

D A Hardman1, C R Pullinger, R L Hamilton, J P Kane, M J Malloy.   

Abstract

We have previously described a disorder, normotriglyceridemic abetalipoproteinemia, that is characterized by the virtual absence of plasma low density lipoproteins and complete absence of apoB-100, but with apparently normal secretion of triglyceride-rich lipoproteins containing apoB-48. The patient's plasma lipoproteins were shown on polyacrylamide gels and by antibody mapping to have a new truncated apoB variant, apoB-50, circulating along with her apoB-48. We have found this individual to be homozygous for a single C-to-T nucleotide substitution at apoB codon 2252, which produces a premature in-frame stop codon. Thus, this is a rare example of homozygous hypobetalipoproteinemia. Electron photomicrographs revealed that the diameters of particles in the d less than 1.006 g/ml lipoprotein fraction, in both the postprandial and postabsorptive state, are bimodally distributed. The molar ratio of apoE to apoB in these particles is 3.5:1, similar to normal VLDL. The plasma LDL interval contains both spherical and cuboidal particles. Autologous reinfusion of labeled d less than 1.006 g/ml lipoproteins showed exponential disappearance from plasma, with an apparent half-removal time of 50 min, somewhat slower than for normal chylomicrons but within the normal range for VLDL. The calculated production rate for apoB was within the normal range in this subject. A very small amount of label was found briefly in the IDL fraction, but none at any time in LDL or HDL. Therefore, because LDL particles that contain apoB-50 lack the putative ligand domain of the LDL receptor, we conclude that the very low level of LDL is due to the rapid removal of the abnormal VLDL particles before their conversion to LDL can take place.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939657      PMCID: PMC295713          DOI: 10.1172/JCI115490

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Homozygous hypobetalipoproteinemia with spared chylomicron formation.

Authors:  Y Harano; H Kojima; T Nakano; M Harada; A Kashiwagi; Y Nakajima; T H Hidaka; T Ohtsuki; T Suzuki; A Tamura
Journal:  Metabolism       Date:  1989-01       Impact factor: 8.694

3.  Two distinct truncated apolipoprotein B species in a kindred with hypobetalipoproteinemia.

Authors:  E S Krul; M Kinoshita; P Talmud; S E Humphries; S Turner; A C Goldberg; K Cook; E Boerwinkle; G Schonfeld
Journal:  Arteriosclerosis       Date:  1989 Nov-Dec

4.  Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the formation of buoyant, triglyceride-rich lipoproteins.

Authors:  S G Young; S T Hubl; R S Smith; S M Snyder; J F Terdiman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

5.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

6.  The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life.

Authors:  C R Pullinger; J D North; B B Teng; V A Rifici; A E Ronhild de Brito; J Scott
Journal:  J Lipid Res       Date:  1989-07       Impact factor: 5.922

7.  The molecular basis of truncated forms of apolipoprotein B in a kindred with compound heterozygous hypobetalipoproteinemia.

Authors:  P Talmud; L King-Underwood; E Krul; G Schonfeld; S Humphries
Journal:  J Lipid Res       Date:  1989-11       Impact factor: 5.922

Review 8.  The mysteries of lipoprotein(a).

Authors:  G Utermann
Journal:  Science       Date:  1989-11-17       Impact factor: 47.728

9.  A monoclonal-antibody-based enzyme-linked immunosorbent assay of lipoprotein(a).

Authors:  W L Wong; D L Eaton; A Berloui; B Fendly; P E Hass
Journal:  Clin Chem       Date:  1990-02       Impact factor: 8.327

10.  Hypobetalipoproteinemia due to an apolipoprotein B gene exon 21 deletion derived by Alu-Alu recombination.

Authors:  L S Huang; M E Ripps; S H Korman; R J Deckelbaum; J L Breslow
Journal:  J Biol Chem       Date:  1989-07-05       Impact factor: 5.157

View more
  3 in total

Review 1.  Insights from human congenital disorders of intestinal lipid metabolism.

Authors:  Emile Levy
Journal:  J Lipid Res       Date:  2014-11-11       Impact factor: 5.922

Review 2.  Optic atrophies in metabolic disorders.

Authors:  Marjan Huizing; Brian P Brooks; Yair Anikster
Journal:  Mol Genet Metab       Date:  2005-09-27       Impact factor: 4.797

3.  Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis.

Authors:  Mindy C W Lam; Janakie Singham; Robert A Hegele; Maziar Riazy; Matti A Hiob; Gordon Francis; Urs P Steinbrecher
Journal:  Case Rep Gastroenterol       Date:  2012-07-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.